Ben Ponvilawan
Impact in
- Nephrology top 10%
- Parathyroid Disorders and Treatments
- Gout, Hyperuricemia, Uric Acid
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 5
- Hematology 13
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Nipith Charoenngam (41 shared papers)Patompong Ungprasert (28 shared papers)Thanitsara Rittiphairoj (14 shared papers)Aunchalee Jaroenlapnopparat (11 shared papers)Phuuwadith Wattanachayakul (7 shared papers)Janakiraman Subramanian (6 shared papers)Weerapat Owattanapanich (5 shared papers)Abdul Wali Khan (2 shared papers)
- Journals
- Blood (6 papers)Frontiers in Oncology (3 papers)Journal of Clinical Oncology (3 papers)Endocrine Practice (2 papers)Clinical Lung Cancer (2 papers)
- Partner nations
- United StatesThailandGermany
In The Last Decade
Ben Ponvilawan
65 papers receiving 482 citations
Peers
Comparison fields: 5 of 66
- Nephrology 53
- Hematology 67
- Hepatology 32
- Dermatology 29
- Genetics 33
Countries citing papers authored by Ben Ponvilawan
This map shows the geographic impact of Ben Ponvilawan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Ponvilawan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Ponvilawan more than expected).
Fields of papers citing papers by Ben Ponvilawan
This network shows the impact of papers produced by Ben Ponvilawan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Ponvilawan. The network helps show where Ben Ponvilawan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben Ponvilawan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 25 | |
| 2 | 2023 | 25 | |
| 3 | 2020 | 23 | |
| 4 | 2022 | 21 | |
| 5 | 2020 | 20 | |
| 6 | 2019 | 18 | |
| 7 | 2022 | 17 | |
| 8 | 2024 | 16 | |
| 9 | 2023 | 16 | |
| 10 | 2024 | 15 | |
| 11 | 2020 | 14 | |
| 12 | 2019 | 13 | |
| 13 | 2020 | 12 | |
| 14 | 2021 | 12 | |
| 15 | 2022 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2023 | 11 | |
| 18 | 2021 | 11 | |
| 19 | 2022 | 11 | |
| 20 | 2023 | 11 |
About Ben Ponvilawan
Ben Ponvilawan is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Genetics and Molecular Biology, having authored 79 papers that have together received 489 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (5 papers), Vitamin D Research Studies (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer Mechanisms and Therapy (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Nephrology (53 citations), Hematology (67 citations), Hepatology (32 citations), Dermatology (29 citations) and Genetics (33 citations). Ben Ponvilawan has collaborated with scholars based in United States, Thailand and Germany. Frequent co-authors include Nipith Charoenngam, Patompong Ungprasert, Thanitsara Rittiphairoj, Aunchalee Jaroenlapnopparat, Phuuwadith Wattanachayakul, Janakiraman Subramanian, Weerapat Owattanapanich, Abdul Wali Khan, Florian Kuchenbauer and Claudie Roy. Their work appears in journals such as Blood, Frontiers in Oncology, Journal of Clinical Oncology, Endocrine Practice and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.